VAERS Explorer
Back to explore

Report #2849738

Received Jul 15, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
MN
Recovered
Unknown
Vaccinated
Mar 6, 2025
Onset
May 15, 2025
Days to onset
70
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HEPHEP B (HEPLISAV-B)DYNAVAX TECHNOLOGIES CORPORATION1——

Symptoms (1)

Inappropriate schedule of product administration

Symptom narrative

Heplisav-B Dose On 6 March 2025, Engerix-B Given As Second Dose By Accident On 15 May 2025.; Inappropriate Schedule of Vaccine Administered; Initial report received on 23-Jun-2025. A nurse reported that a 54-year-old male received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization and was given ENGERIX-B as the second dose by accident. No medical history or concomitant medications were reported. On 06-Mar-2025, the patient received dose 1 of a hepatitis B vaccine [HEPLISAV-B (lot number, expiration date, NDC number, route, and site not available)]. On 15-May-2025, 71 days after receiving HEPLISAV-B, the patient received dose 2 of a hepatitis B vaccine [ENGERIX-B (lot number not provided)]. The reporter was inquiring about the time interval between HEPLISAV-B doses in the event ENGERIX-B was given as the second dose by accident. No additional information was reported. The reporter declined to provide further information. Company Comment: The company assessed the events as non-serious.; Sender's Comments: The company assessed the events as non-serious.

Other medications

Engerix b